[
    [
        {
            "time": "",
            "original_text": "28家公司集体大涨，医药另一细分行业要崛起了？",
            "features": {
                "keywords": [
                    "公司",
                    "大涨",
                    "医药",
                    "细分行业",
                    "崛起"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "28家公司集体大涨，医药另一细分行业要崛起了？",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "上实集团旗下上海医药利伐沙班片获批生产 其疗效可供患者长期使用",
            "features": {
                "keywords": [
                    "上实集团",
                    "上海医药",
                    "利伐沙班片",
                    "获批生产",
                    "疗效",
                    "长期使用"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上实集团旗下上海医药利伐沙班片获批生产 其疗效可供患者长期使用",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "上海医药：公司2020年中药板块收入超70亿，旗下7家核心中药企业",
            "features": {
                "keywords": [
                    "上海医药",
                    "2020年",
                    "中药板块",
                    "收入",
                    "70亿",
                    "核心中药企业"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药：公司2020年中药板块收入超70亿，旗下7家核心中药企业",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        }
    ]
]